Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

6.230 +0.730 (+13.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 313,182
Open 5.440
Bid (Size) 6.010 (100)
Ask (Size) 6.200 (2,000)
Prev. Close 5.500
Today's Range 5.310 - 6.290
52wk Range 1.970 - 7.775
Shares Outstanding 107,808,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
From Silence Therapeutics plc
Via Business Wire

Performance

YTD
+1.3%
+1.3%
1 Month
+44.9%
+44.9%
3 Month
-10.5%
-10.5%
6 Month
+9.5%
+9.5%
1 Year
+31.4%
+31.4%

More News

Read More
News headline image
Silence Therapeutics Announces Leadership Changes
From Silence Therapeutics plc
Via Business Wire
News headline image
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake ↗
Via The Motley Fool
News headline image
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings) ↗
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
Via Benzinga
News headline image
Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)
From Silence Therapeutics plc
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Silence Therapeutics to Participate in September Investor Conferences
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence (SLN) Q2 Revenue Drops 71% ↗
Via The Motley Fool
News headline image
Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
From Silence Therapeutics plc
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
From Silence Therapeutics plc
Via Business Wire
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
From Silence Therapeutics plc
Via Business Wire
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15 ↗
Via Talk Markets
Topics Stocks / Equities
News headline image
Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
Via Benzinga

Frequently Asked Questions

Is Silence Therapeutics Plc - American Depository Share publicly traded?
Yes, Silence Therapeutics Plc - American Depository Share is publicly traded.
What exchange does Silence Therapeutics Plc - American Depository Share trade on?
Silence Therapeutics Plc - American Depository Share trades on the Nasdaq Stock Market
What is the ticker symbol for Silence Therapeutics Plc - American Depository Share?
The ticker symbol for Silence Therapeutics Plc - American Depository Share is SLN on the Nasdaq Stock Market
What is the current price of Silence Therapeutics Plc - American Depository Share?
The current price of Silence Therapeutics Plc - American Depository Share is 6.230
When was Silence Therapeutics Plc - American Depository Share last traded?
The last trade of Silence Therapeutics Plc - American Depository Share was at 03/06/26 04:00 PM ET
What is the market capitalization of Silence Therapeutics Plc - American Depository Share?
The market capitalization of Silence Therapeutics Plc - American Depository Share is 671.65M
How many shares of Silence Therapeutics Plc - American Depository Share are outstanding?
Silence Therapeutics Plc - American Depository Share has 672M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.